<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02436954</url>
  </required_header>
  <id_info>
    <org_study_id>KUH1160084</org_study_id>
    <nct_id>NCT02436954</nct_id>
  </id_info>
  <brief_title>Regional Cerebral Oxygen Saturation in Laparoscopic Surgery</brief_title>
  <official_title>Impact of Neuromuscular Blockade on Cerebral Oxygen Saturation in Laparoscopic Surgery Employ Carbon Dioxide-pneumoperitoneum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Konkuk University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Konkuk University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      While few studies have determined the optimal intra-abdominal CO2 insufflation pressure to&#xD;
      achieve optimal surgical condition during LCs with deep-NMB and moderate-NMB in laparoscopic&#xD;
      cholecystectomy (LC), previous studies suggested that the use of deep neuromuscular blockade&#xD;
      (deep-NMB) can improve surgical condition and reduce the pressure for CO2 insufflation to&#xD;
      achieve &quot;optimal surgical space condition&quot;.&#xD;
&#xD;
      this difference in the pressure of intra-abdominal CO2 insufflation due to different&#xD;
      strategies employing deep-NMB and moderate-NMB for LC may produce possible difference in&#xD;
      patient's respiratory pattern and cerebral oxygenation. Although previous study (studies)&#xD;
      showed that intra-abdominal CO2 insufflation (10-12 mmHg) decreases cerebral oxy-hemoglobin&#xD;
      (HbO2) and total Hb measured by near-infrared spectroscopy (NIRS) during laparoscopic&#xD;
      cholecystectomy (LC), few studies have speculated possible impact of different degree of NMB&#xD;
      and intra-abdominal CO2 insufflation pressure on patient's cardiorespiratory profile and&#xD;
      cerebral oxygenation, so far.&#xD;
&#xD;
      The present study determines and compares the changes CO2 absorption and cerebral oxygenation&#xD;
      (cerebral perfusion) after applying CO2 insufflation with different intra-peritoneal pressure&#xD;
      8 vs 12 mmHg during deep-NMB.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>regional cerebral oxygen saturation 1</measure>
    <time_frame>1 min</time_frame>
    <description>1 min after the initiation of pneumoperitonium</description>
  </primary_outcome>
  <primary_outcome>
    <measure>regional cerebral oxygen saturation 2</measure>
    <time_frame>2 min</time_frame>
    <description>2 min after the initiation of pneumoperitonium</description>
  </primary_outcome>
  <primary_outcome>
    <measure>regional cerebral oxygen saturation 3</measure>
    <time_frame>3 min</time_frame>
    <description>2 min after the initiation of pneumoperitonium</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>end-tidal carbon dioxide 1</measure>
    <time_frame>1 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>end-tidal carbon dioxide 2</measure>
    <time_frame>2 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>end-tidal carbon dioxide 3</measure>
    <time_frame>3 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>repiratory rate</measure>
    <time_frame>3 min</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cholecyctitis</condition>
  <arm_group>
    <arm_group_label>CO2 insufflation at intra-abdominal pressure 8 mmHg</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>CO2 insufflation with intra-abdominal pressure 8 mmHg during deep-NMB</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CO2 insufflation at intra-abdominal pressure 12 mmHg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CO2 insufflation with intra-abdominal pressure 12 mmHg during deep-NMB</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CO2 insufflation at intra-abdominal pressure 8 mmHg</intervention_name>
    <description>insufflation of CO2 gas into peritoneum for maintaining the pressure of 8 mmHg</description>
    <arm_group_label>CO2 insufflation at intra-abdominal pressure 8 mmHg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CO2 insufflation at intra-abdominal pressure 12 mmHg</intervention_name>
    <description>insufflation of CO2 gas into peritoneum for maintaining the pressure of 12 mmHg</description>
    <arm_group_label>CO2 insufflation at intra-abdominal pressure 12 mmHg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  cholecystitis&#xD;
&#xD;
          -  provision of written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  COPD&#xD;
&#xD;
          -  asthma&#xD;
&#xD;
          -  low LV ejection fraction&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 18, 2015</study_first_submitted>
  <study_first_submitted_qc>May 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2015</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Konkuk University Medical Center</investigator_affiliation>
    <investigator_full_name>Tae-Yop Kim, MD PhD</investigator_full_name>
    <investigator_title>Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

